Study finds less risk of birth defects in newer epilepsy drugs

Danish researchers wrote in the Journal of the American Medical Association that newer epilepsy drugs, including lamotrigine and oxcarbazepine, taken during pregnancy didn't elevate the risk of birth defects. They found that 3.2% of 1,532 babies born to mothers who took such medications developed a major defect, but noted that before pregnancy, many of the mothers used phenobarbital, phenytoin and other older epilepsy drugs, which have been previously linked to higher risk of birth defects.

View Full Article in:

Los Angeles Times (tiered subscription model) · HealthDay News

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Learning Assessment Specialist at India's Leading K12 Education Enterprise
XSEED Education (India)
Gurgaon (New Delhi Area)
RFP Specialist, Contract Position
ASCD
Alexandria, VA
DIRECTOR OF LANGUAGE DEVELOPMENT
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ